Cloning and functional characterization of a σ receptor from rat brain

Journal of Neurochemistry

Volumn 70, Issue 3, 1998, Pages 922-931

  Seth, Pankaj ^a   Fei, You Jun ^a   Li, Hui W ^a   Huang, Wei ^a   Leibach, Frederick H ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Brain; Functional expression; Primary structure; Steroids; ligands; receptor

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; CLORGYLINE; COMPLEMENTARY DNA; ESTRADIOL; HALOPERIDOL; LIGAND; MESSENGER RNA; OPIATE RECEPTOR; PENTAZOCINE; PENTOXYVERINE; POLYADENYLATED RNA; PRECLAMOL; PRENYLAMINE; PROGESTERONE; RECEPTOR SUBTYPE; TESTOSTERONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALIA; CAVIA PORCELLUS; MAMMALIA; MINK CELL FOCUS-FORMING VIRUS; SUS SCROFA; TRIXIS;

EID: 0031892683     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70030922.x     Document Type: Article

References (44)

1. Angulo J. A., Cadet J. L., and McEwen B. S. (1990) σ receptor blockade by BMY 14802 affects enkephalinergic and tachykinin cells differentially in the striatum of the rat. Eur. J. Pharmacol. 175, 225-228.
2. Bouchard P., Dumont Y., Fournier A., St.-Pierre S., and Quirion R. (1993) Evidence for in vivo interactions between neuropeptide Y-related peptides and a receptors in the mouse hippocampal formation. J. Neurosci. 13, 3926-3931.
3. Brent P. J., Herd L., Saunders H., Sim A. T. R., and Dunkley P. R. (1997) Protein phosphorylation and calcium uptake into rat forebrain synaptosomes: modulation by the σ ligand 1,3-ditolylguanidine. J. Neurochem. 68, 2201-2211.
4. Britton P., Lu X. C. M., Laskosky M. S., and Tortella F. C. (1997) Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. Life Sci. 60, 1729-1740.
5. Chien C. C. and Pasternak G. W. (1994) Selective antagonism of opioid analgesia by a sigma system. J. Pharmacol. Exp. Ther. 271, 1583-1590.
6. Chien C. C. and Pasternak G. W. (1995) Sigma antagonists potentiate opioid analgesia in rats, Neurosci. Lett. 190, 137-139.
7. 125I]3′-(-)-iodopentazocine, a selective σ1 receptor ligand. Eur. J. Pharmacol. 321, 361-368.
8. De Coster M. A., Klette K. L., Knight E. S., and Tortella F. C. (1995) σ receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671, 45-53.
9. 3H](+)-pentazocine-defined σ recognition sites by phenytoin. Life Sci. 53, 41-48.
10. Della-Puppa A. and London E. D. (1989) Cerebral metabolic effects of σ ligands in the rat. Brain Res. 505, 283-290.
11. Eisenberg D., Schwarz E., Komaromy M., and Wall R. (1984) Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179, 125-142.
12. Ferris C. D., Hirsch D. J., Brooks B. P., and Snyder S. H. (1991) σ receptors: from molecule to man. J. Neurochem. 57, 729-737.
13. Garza H. H. Jr., Mayo S., Bowen W. D., De Costa B. R., and Carr D. J. J. (1993) Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes. J. Immunol. 151, 4672-4680.
14. 2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J. Biol. Chem. 270, 7551-7557.
15. Hanner M., Moebius F. F., Flandorfer A., Knaus H. G., Striessnig J., Kempner E., and Glossmann H. (1996) Purification, molecular cloning, and expression of the mammalian sigma 1-binding site. Proc. Natl. Acad. Sci. USA 93, 8072-8077.
16. Hellewell S. B. and Bowen W. D. (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 527, 244-253.
17. Itzhak Y. and Stein I. (1990) Sigma binding sites in the brain: an emerging concept of multiple sites and their relevance for psychiatric disorders. Life Sci. 47, 1073-1081.
18. 3H] phenyl) guanidine. Proc. Natl. Acad. Sci. USA 85, 2844-2848.
19. Kekuda R., Prasad P. D., Fei Y. J., Leibach F. H., and Ganapathy V. (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. Biophys. Res. Commun. 229, 553-558.
20. 3H]dextromethorphan and σ ligands to guinea pig brain. Life Sci. 48, 543-550.
21. Levant B. and Nemeroff C. B. (1990) Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate. J. Pharmacol. Exp. Ther. 254, 330-335.
22. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., and Gilbert P. E. (1976) The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517-532.
23. 3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes. J. Pharmacol. Exp. Ther. 257, 547-554.
24. Moebius F. F., Burrows G. G., Hanner M., Schmid E., Striessnig J., and Glossman H. (1993a) Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the σ1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol. Pharmacol. 44, 966-971.
25. Moebius F. F., Burrows G. G., Striessnig J., and Glossman H. (1993b) Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Mol. Pharmacol. 43, 139-148.
26. Moebius F. F., Striessnig J., and Glossmann H. (1997) The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol. Sci. 18, 67-70.
27. Monnet F. P., Debonnel G., Junien J. L., and De Montigny C. (1990) N-Methyl-D-aspartate induced neuronal activation is selectively modulated by a receptors. Eur. J. Pharmacol. 179, 441-445.
28. 3 dorsal hippocampus. II. Involvement of a subtype of sigma receptors. J. Pharmacol. Exp. Ther. 263, 1219-1225.
29. Musacchio J. M., Klein M., and Santiago L. J. (1988) High affinity dextromethorphan binding sites in the guinea pig brain: further characterization and allosteric interactions. J. Pharmacol. Exp. Ther. 247, 424-431.
30. 3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Mol. Pharmacol. 35, 1-5.
31. Prasad P. D., Li H. W., Fei Y.-J., Ganapathy M. E., Fujita T., Plumley L. H., Yang-Feng T. L., Leibach F. H., and Ganapathy V. (1998) Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 σ receptor gene. J. Neurochem. 70, 443-451.
32. Quirion R., Bowen W. D., Itzhak Y., Junien J. L., Musacchio J. M., Rothman R. B., Tam S. W., and Taylor D. P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13, 85-86.
33. Ramamoorthy J. D., Ramamoorthy S., Mahesh V. B., Leibach F. H., and Ganapathy V. (1995) Cocaine-sensitive σ-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells. Endocrinology 136, 924-932.
34. Riviere P. J. M., Pascaud X., Junien J. L., and Porreca F. (1990) Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site. Eur. J. Pharmacol. 187, 557-559.
35. Roman F. J., Pascaud X. P., Duffy O., Vauche D., Martin B., and Junien J. L. (1989) Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites. Eur. J. Pharmacol. 174, 301-302.
36. 3H] 1,3-di(2-tolyl)-guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. Mol. Pharmacol. 39, 222-232.
37. Silve S., Dupuy P. H., Labit-Lebouteiller C., Kaghad M., Chalon P., Rahier A., Taton M., Lupker J., Shire D., and Loison G. (1996) Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits Δ8-Δ7 sterol isomerase activity in yeast. J. Biol. Chem. 271, 22434-22440.
38. Su T. P. (1991) σ receptors: putative links between nervous, endocrine and immune systems. Eur. J. Biochem. 200, 633-642.
39. Su T. P., London E. D., and Jaffe J. H. (1988) Steroid binding at σ receptor suggests a link between endocrine, nervous, and immune systems. Science 240, 219-221.
40. Vilner B. J., John C. S., and Bowen W. D. (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55, 408-413.
41. Vogeli G. and Kaytes P. S. (1987) Amplification, storage, and replication of libraries. Methods Enzymol. 152, 407-415.
42. Wachtel S. R. and White F. J. (1988) Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. J. Pharmacol. Exp. Ther. 244, 410-416.
43. Walker J. M., Bowen W. D., Walker F. O., Matsumoto R. R., De Costa B., and Rice K. C. (1990) Sigma receptors: biology and function. Pharmacol. Rev. 42, 355-402.
44. Witkin J. M. (1994) Pharmacotherapy of cocaine abuse: preclinical development. Neurosci. Behav. Rev. 18, 121-142.